CompoAtlas

First-Line-of-Defense Softgel

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Source : Tagetes erecta - Oléorésine (herbe en fleurs)

10 mgNot calculated
Ribes nigrum

Source : Ribes nigrum - graine

Potency : 15 % gamma-Linolenic acid

200 mgNot calculated
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Source : Tagetes erecta - Oléorésine (herbe en fleurs)

2 mgNot calculated
trans-Resvératrol

Source : Reynoutria Japonica - racine

60 mgNot calculated
2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one

Source : Styphnolobium japonicum - fleur

60 mgNot calculated
Vitamine C

Source : Ascorbate de calcium

65 mg65,000 µg

Non-medicinal ingredients

Poudre de caroube, Glycérine, Eau purifiée, Gélatine, Lécithine, Cire d'abeille jaune

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Antioxidant for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. An antioxidant for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Ventura Health Sciences Corporation
NPN or DIN-HM
80090204
Status
Active licence
Licence date
17 January 2019
Revision date
25 January 2019
Form
Capsule, molle
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80090204

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “First-Line-of-Defense Softgel”, https://compoatlas.com/en/supplements/canada/80090204-first-line-of-defense-softgel, updated 25 January 2019.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line